| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_392f3d3ce6a84adca5d6bc29696560b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f36ad1c2565ef4b3c91fed109e325b5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115c61dc9591780d99d2c751101454b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f17b9a768549cb571ff642a64795d056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4ead6158fa635796a5fa4d48ffc357a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2002-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22158e8ab54b539017884199bf9925da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1afb1cb8ba70a8b765f72362dbfd325c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7359ac7c49d00693c2722b6e87fbd441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aa80c5641ce63c7261dfef3a57fefd2 |
| publicationDate |
2003-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03027146-A1 |
| titleOfInvention |
Use of cardiotrophin in hepatic diseases |
| abstract |
The invention relates to the use of cardiotrophin in hepatic diseases. The invention describes the increased expression of cardiotrophine (CT-1) during the hepatic regeneration process which coincides with the maximum proliferation of hepatocytes. Said invention also relates to the role of CT-1 as a hepatic regeneration stimulator. Moreover, said invention details the hepatoprotective role of CT-1 in different acute hepatic injury models. All of the above reveals the importance of the use of CT-1 in the production of compositions used in the treatment of hepatopathies. The invention relates to said use of CT-1 in different forms and methods, including the recombinant protein and the use of gene sequences that code for CT-1. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004249340-B2 |
| priorityDate |
2001-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |